Cutler Group LP Surface Oncology, Inc. Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	BUY	$1.42 - $3.15 $12,212 - $27,090	8,600 Added 195.45%	13,000 $0
Q1 2022 Apr 14, 2022	BUY	$2.65 - $5.08 $2,915 - $5,588	1,100 Added 33.33%	4,400 $0
Q4 2021 Jan 18, 2022	BUY	$4.73 - $7.9 $15,609 - $26,070	3,300 New	3,300 $0
Q3 2021 Oct 26, 2021	SELL	$5.16 - $7.98 $6,192 - $9,576	-1,200 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$6.45 - $9.09 $1,290 - $1,818	200 Added 20.0%	1,200 $0
Q1 2021 Apr 26, 2021	BUY	$7.25 - $13.82 $2,175 - $4,146	300 Added 42.86%	1,000 $0
Q4 2020 Jan 21, 2021	BUY	$6.87 - $10.48 $4,809 - $7,336	700 New	700 $2,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.